Wedmont Private Capital lessened its holdings in shares of CVS Health Co. (NYSE:CVS – Free Report) by 21.5% in the fourth ...

Claro Advisors LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 59.7% during the fourth ...

Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...

Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...

The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...

A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

Pharmacies like Snyders rely on reimbursements to make ends meet. When his business dispenses prescriptions, the repayment ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...